Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.

Hiển thị phiên bản (1) khác

BACKGROUND: New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunolo...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Meyer, J, Harris, SA, Satti, I, Poulton, I, Poyntz, H, Tanner, R, Rowland, R, Griffiths, K, Fletcher, H, Mcshane, H
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2013

Những quyển sách tương tự

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Bằng: Meyer, J, et al.
Được phát hành: (2013)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
Bằng: Harris, S, et al.
Được phát hành: (2011)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
Bằng: Rowland, R, et al.
Được phát hành: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Bằng: Pathan, A, et al.
Được phát hành: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
Bằng: Pathan, A, et al.
Được phát hành: (2012)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
Bằng: Minassian, A, et al.
Được phát hành: (2011)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
Bằng: Whelan, K, et al.
Được phát hành: (2009)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Bằng: Harris, S, et al.
Được phát hành: (2013)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
Bằng: Thomas, Z, et al.
Được phát hành: (2014)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
Bằng: Mcshane, H
Được phát hành: (2008)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
Bằng: Kathryn T. Whelan, et al.
Được phát hành: (2011-01-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
Bằng: Harris, SA, et al.
Được phát hành: (2014)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
Bằng: Griffiths, K, et al.
Được phát hành: (2011)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
Bằng: Rowland, R, et al.
Được phát hành: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
Bằng: Riste, M, et al.
Được phát hành: (2021)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Bằng: Minhinnick, A, et al.
Được phát hành: (2016)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Brookes, R, et al.
Được phát hành: (2008)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
Bằng: Wajja, A, et al.
Được phát hành: (2017)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Bằng: Satti, I, et al.
Được phát hành: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
Bằng: Satti, I, et al.
Được phát hành: (2014)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
Bằng: Betts, G, et al.
Được phát hành: (2012)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Bằng: Sander, C, et al.
Được phát hành: (2009)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Roger H Brookes, et al.
Được phát hành: (2008-08-01)

CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults
Bằng: Beveridge, N, et al.
Được phát hành: (2011)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Bằng: Tameris, M, et al.
Được phát hành: (2014)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
Bằng: Hawkridge, T, et al.
Được phát hành: (2008)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
Bằng: Tameris, M, et al.
Được phát hành: (2014)

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <em>M.tb</em>-Infected Adults
Bằng: Michael Riste, et al.
Được phát hành: (2021-04-01)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
Bằng: Gareth Betts, et al.
Được phát hành: (2012-01-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
Bằng: Roger H. Brookes, et al.
Được phát hành: (2011-01-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
Bằng: Anne Wajja, et al.
Được phát hành: (2017-05-01)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
Bằng: Ota, M, et al.
Được phát hành: (2011)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
Bằng: Ota, M, et al.
Được phát hành: (2011)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
Bằng: Sheehan, S, et al.
Được phát hành: (2015)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
Bằng: Matsumiya, M, et al.
Được phát hành: (2014)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
Bằng: Dieye, T, et al.
Được phát hành: (2013)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
Bằng: Matsumiya, M, et al.
Được phát hành: (2014)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
Bằng: Mcshane, H, et al.
Được phát hành: (2005)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Bằng: Michele Tameris, et al.
Được phát hành: (2014-01-01)

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
Bằng: Wajja, A, et al.
Được phát hành: (2024)